Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA binding motif protein 45 (RBM45) is a highly conserved RNA-binding protein expressed predominantly in the fetal brain and decreasing with development. It contains three RNA recognition motif (RRM) domains, each capable of binding RNA sequences, most notably GAC and GACG motifs, and a central HOA (homo-oligomer assembly) domain responsible for self-association and interaction with other RBPs such as FUS and TDP-43. RBM45 localizes chiefly in the nucleus but can shuttle to the cytoplasm, where it forms aggregates especially in neurons and glia affected by ALS and FTLD. It functions in pre-mRNA splicing by binding to intronic splicing enhancers and is essential for proper maturation of select mRNAs. Abnormalities in RBM45, including mutations and protein aggregation, are implicated in neurodegenerative diseases, but direct therapeutic targeting has not been established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA binding motif protein 45 (RBM45).